- Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy
-
Dutta D, Kataki KJ, George S, Reddy SK, Sashidharan A, Kannan R, Madhavan R, Nair H, Tatineni T, Holla R
- KMID: 2509951
- Radiat Oncol J.
- 2020 Dec;38(4):253-261.
- doi: 10.3857/roj.2020.00472
Background: Evaluate morbidities and “quality” of fiducial marker placement in primary liver tumours (hepatocellular carcinoma [HCC]) for CyberKnife. Materials and Methods: Thirty-six HCC with portal vein thrombosis(PVT) were evaluated for “quality”... -
- CITED
-
- Close
- SHARE
-
- Close
